Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
33.03
-1.86 (-5.33%)
Jun 20, 2025, 1:43 PM - Market open

Legend Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
6,0875,96910,9388,3577,1753,735
Upgrade
Market Cap Growth
-38.93%-45.43%30.89%16.46%92.11%-
Upgrade
Enterprise Value
5,5725,1049,8357,6956,6133,163
Upgrade
Last Close Price
34.8932.5460.1749.9246.6128.16
Upgrade
PS Ratio
8.789.5238.3671.42104.2649.80
Upgrade
PB Ratio
6.315.748.7411.239.376.25
Upgrade
P/TBV Ratio
6.125.758.7711.289.436.28
Upgrade
EV/Sales Ratio
7.658.1434.4965.7696.0842.17
Upgrade
Debt / Equity Ratio
0.360.340.260.380.160.01
Upgrade
Asset Turnover
0.430.360.180.100.080.15
Upgrade
Inventory Turnover
25.0829.9135.3566.27176.58157.02
Upgrade
Quick Ratio
5.004.496.773.594.115.09
Upgrade
Current Ratio
5.204.626.923.694.145.14
Upgrade
Return on Equity (ROE)
-20.00%-15.45%-51.94%-59.11%-59.19%-71.12%
Upgrade
Return on Assets (ROA)
-8.77%-10.84%-17.39%-23.37%-26.75%-28.32%
Upgrade
Return on Capital (ROIC)
-10.33%-12.84%-21.19%-29.86%-33.05%-37.86%
Upgrade
Earnings Yield
-3.51%-2.97%-4.74%-5.34%-5.62%-7.13%
Upgrade
FCF Yield
-4.40%-2.65%-3.78%-2.66%-3.35%-6.67%
Upgrade
Buyback Yield / Dilution
-1.67%-3.84%-10.71%-12.91%-19.21%-18.15%
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q